Journal article icon

Journal article

Lipid degradation promotes prostate cancer cell survival.

Abstract:

Prostate cancer is the most common male cancer and androgen receptor (AR) is the major driver of the disease. Here we show that Enoyl-CoA delta isomerase 2 (ECI2) is a novel AR-target that promotes prostate cancer cell survival. Increased ECI2 expression predicts mortality in prostate cancer patients (p = 0.0086). ECI2 encodes for an enzyme involved in lipid metabolism, and we use multiple metabolite profiling platforms and RNA-seq to show that inhibition of ECI2 expression leads to decreased...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.18632/oncotarget.16123

Authors


More by this author
Role:
Author
ORCID:
0000-0003-2931-3652
More by this author
Role:
Author
ORCID:
0000-0002-0020-5626
Expand authors...
Norwegian Cancer Society More from this funder
Southern and Eastern Norway Regional Health Authority More from this funder
Norwegian Research Council More from this funder
Movember Prostate Cancer Centre of Excellence. More from this funder
Expand funders...
Publisher:
Impact Journals Publisher's website
Journal:
Oncotarget Journal website
Volume:
8
Issue:
24
Pages:
38264-38275
Publication date:
2017-03-01
Acceptance date:
2017-03-01
DOI:
EISSN:
1949-2553
ISSN:
1949-2553
Pmid:
28415728
Source identifiers:
817469
Language:
English
Keywords:
Pubs id:
pubs:817469
UUID:
uuid:bd91bd87-f47a-41d5-8e80-2c032d6aff16
Local pid:
pubs:817469
Deposit date:
2018-01-11

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP